Search results
Results From The WOW.Com Content Network
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia , the company is headquartered in Exton, Pennsylvania .
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
As of September 19, 2018, the price for the generic equivalent was $10.01 per tablet from West-ward Pharmaceuticals Corp., Edenbridge Pharmaceuticals, LLC and Oceanside Pharmaceuticals. As of July 22, 2020 the price decreased to $3.45 with availability from additional generic manufacturers.
On Thursday, West Pharmaceutical Services, Inc. (NYSE:WST) reported adjusted EPS of $1.85, down from $2.16 a year ago, beating the consensus of $1.50. The designer and manufacturer of injectable ...
Biotech and pharmaceutical companies in the New York metropolitan area represent a significant and growing economic component of the New York metropolitan area, [1] [2] the most populous combined statistical area in the United States [3] and one of the most populous megacities in the world.
G.D. Searle, LLC is a wholly owned subsidiary of Pfizer. [1] It is currently a trademark company and subsidiary of Pfizer, operating in more than 43 countries. It also operates as a distribution trademark for various pharmaceuticals that were developed by G. D. Searle & Company (often referred to as Searle).
Alza was a major pioneer in the field of drug delivery systems, bringing over 20 prescription pharmaceutical products to market, and employing about 10,000 people during 20 years. [2] In 2001, Alza was acquired by Johnson & Johnson via a stock-for-stock transaction worth US$10.5 billion.
Alvogen is a private, US-based pharmaceuticals company founded in 2009. Since 2015, it has been majority-owned by CVC Capital Partners and Temasek Holdings. [2] Alvogen focuses on so-called 'difficult-to-make' generic drugs and injectables, and both produces its own products and markets the products of brand name pharmaceutical companies.